The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease.
The human leukocyte antigen (HLA) system could play an essential role in multiple myeloma (MM) disease control. This report describes the results comparing HLA-DRB1 phenotypic frequencies in 181 MM patients (53 smoldering/indolent MM and 128 symptomatic MM patients) and healthy individuals. Higher DRB1*01 phenotypic frequencies were found in the smoldering patients compared with symptomatic MM patients (38% vs 14%, P = 0.001) and with the healthy individuals (38% vs 22%, P = 0.01). Additionally, higher DRB1*07 phenotypic frequencies were found in symptomatic MM compared with control population (38% vs 28%, P = 0.01). The present data suggest that HLA-DRB1*01 individuals may have a better ability to efficiently present myeloma-related antigens to immunocompetent cells, which could favor a better immune response against the tumor. This would translate into a more appropriate disease control associated with more indolent disease and prolonged survival.
Alcoceba
M
M
Departamento de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.
Marín
L
L
Balanzategui
A
A
Sarasquete
M E
ME
Martín-Jiménez
P
P
Chillón
M C
MC
Corral
R
R
Pérez-Persona
E
E
Fernández-Calvo
F J
FJ
Hernández
J M
JM
Bladé
J
J
Lahuerta
J J
JJ
González
M
M
San Miguel
J F
JF
García-Sanz
R
R
D017951:Antigen Presentation / Q000235:genetics / Q000276:immunology; D005260:Female; D006684:HLA-DR Antigens / Q000235:genetics* / Q000276:immunology; D059811:HLA-DRB1 Chains; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000235:genetics* / Q000276:immunology / Q000401:mortality; D010641:Phenotype
D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; C497841:HLA-DRB1*01 antigen